Cannabis Biotech

Fort Lauderdale, Florida
Logo for Cannabis Biotech
Is this your profile?

Claim it and begin making changes yourself.

Claim It

About this Organization

Based in Fort Lauderdale, Florida, Cannabis Biotech is a subsidiary of Puget Technologies (OTC: PUGE). The publicly held company is led by President and CEO Ron Leyland.

Cannabis Biotech conducts research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms. Ailments that the company has studied include HIV, cancer, glaucoma and neurological disorders.

Thus far, Cannabis Biotech has developed a number of products that utilize alternative delivery methods. For instance, they have developed nasal spray and trans-dermal skin patches geared towards treatment via cannabinoids. Further, they are developing cannabis infused beverages that utilize natural cannabis-based terpenoids as a flavoring agent.


Ron Leyland
Ron Leyland serves as President and CEO of Puget Technologies, the publicly-traded parent company of Cannabis Biotech. He is responsible for guiding the company’s overall direction, implementing their mission and vision. Further, Leyland is in charge of developing strategic opportunities to increase share-holder value. Before his time with Puget Technology, Leyland founded Nexagen USA in 2002. Leveraging the company’s successful launch of its initial proprietary product, the Jen Fe Diet Patch, he assembled an expert research and development team. They went on to develop a well-accepted product line consisting of patches, pills, lotions and drinks utilizing multiple delivery systems. Leyland …

Similar Companies

Logo for WEEDtv™
Los Angeles, California
WEEDtv is the first television channel dedicated to exclusively covering cannabis-related content.
Logo for Plandai Biotechnology
Plandai Biotechnology
Seattle, Washington
Based in Seattle, Plandai Biotechnology is a publicly-traded company that delivers highly bioavailable, phytonutrient rich extracts under the trademark, Phytofare™. In early 2014, Plandai submitted a request for ministerial dispensation to the Secretary of Parliament of South Africa, asking for the allowance of cannabis research. The company hopes to develop cannabis extract medicines for the treatment of cancer.
Logo for Medical Marijuana Sciences, Inc. (MMS)
Medical Marijuana Sciences, Inc. (MMS)
Silver Spring, Maryland
Medical Marijuana Sciences, Inc. (MMS) is a subsidiary of Nuvilex that was established in early 2013. The initial mission of MMS is to develop treatments, based on constituents of Cannabis, for two of the most serious and deadly forms of cancer – brain and pancreatic cancers.

DISCLAIMER: The professionals and companies described are not associated or affiliated with Medical Jane, and they may not endorse Medical Jane or the information provided. The names of other companies, products and services are the property of their respective owners.

  • Subscribe

    Thank you for subscribing!
    There was a problem subscribing, please try again later.

    Sign-up to receive the latest medical cannabis research, news, and special offers straight to your inbox.

    By subscribing I agree to the Privacy Policy

    Want more exposure?

    Feature your company or event in the directory and get noticed.

    Learn more